Centerra Gold Inc. (CGAU) Stock Analysis

76.0/100
Buy Not Halal Basic Materials
Price $20.24
Market Cap $3.92B
52-Week Change +66.58%

Is CGAU a good investment?

Centerra Gold Inc. (CGAU) has a Plutrex AI rating of 76.0/100 as of November 12, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: Superior forward growth at deep valuation discount: PEG 0.32 (60% below gold industry average 0.79) with 29.95% next-year EPS growth (133% above industry 12.86%) — paying less than half the industry's already-discounted valuation for 2.3x the near-term earnings growth; P/E 9.88x on a 31% CAGR growth company remains a historically rare mispricing vs. industry P/E of 13.07x. Main concern: Significant valuation multiple expansion and revenue deceleration since prior report: P/E expanded 46.4% (from 6.75x to 9.88x) reducing the margin of safety, while revenue growth decelerated 50.3% (from 53.5% to 26.6%) now lagging the industry average of 32.96% — these two simultaneous moves (stock got more expensive + underlying growth slowed at the top line) are the most material new negative developments in 14 days.

Investment Summary

CGAU (Centerra Gold) remains a compelling but nuanced buy at $21.28, anchored by an exceptional growth-valuation mismatch and fortress balance sheet, partially offset by meaningful metric deterioration since the prior report. The core bull case: PEG of 0.32 (up from 0.20 prior, still far below the gold industry average of 0.79), P/E of 9.88x (vs. industry 13.07x) on a company projecting 29.95% next-year EPS growth and 31.22% 5-year EPS CAGR — this remains one of the most asymmetric growth-value setups in the gold sector. The fortress balance sheet (D/E 0.02 vs. industry 0.111; $398M cash) provides substantial downside protection. HOWEVER, two key metric deteriorations must be noted: (1) P/E expanded from 6.75x to 9.88x (+46.4%) — the valuation cushion has compressed materially, though it remains cheap vs. peers; (2) Revenue growth collapsed from 53.5% to 26.6% (-50.3%) — the top-line growth deceleration is significant and partially explains why EPS growth estimates remain robust (cost discipline) but raises questions about the sustainability of the 31%+ EPS CAGR if revenues decelerate further. News sentiment of 96.6/100 is nearly perfect, with Centerra's Thompson Creek molybdenum project delivering 71% rally potential according to recent coverage, gold futures at $4,124.10/oz (+1.21%) providing a strong commodity tailwind, and the NCIB renewal signaling management's confidence in buybacks. The combination of active capital returns, project pipeline, and $4,100+ gold keeps the medium conviction Buy intact — but the entry zone tightens versus 14 days ago due to valuation multiple expansion.

Key Strengths

Key Concerns

Plutrex 10-Factor AI Breakdown

Financial Health
85/100
Growth Potential
65/100
Valuation
70/100
Profitability
80/100
Debt Management
95/100
Analyst Sentiment
45/100
Technical Momentum
60/100
Insider Confidence
62/100
News Sentiment
94/100

Fundamental Analysis

PROFITABILITY: Gross margin 33.4% (vs. industry 54.88% — 39.2% discount), operating margin 42.0% (vs. industry 51.66% — 18.8% discount; notably operating margin exceeds gross margin, characteristic of royalty/streaming structures or favorable non-cash accounting), net margin 24.1% (vs. industry 34.49% — 30.2% discount). ROE 20.83% (vs. industry 25.66% — 18.8% discount but objectively strong in absolute terms). All four profitability metrics lag peers, unchanged from prior report. HEALTH: D/E 0.02 (vs. industry 0.111 — 82% discount; best in peer group), cash $398M (down from $453M prior — $55M reduction worth monitoring), FCF $10.8M (dramatically lower than prior $92.3M FCF — a significant deterioration in cash generation that partially explains the cash balance decline and raises earnings quality questions). VALUATION: P/E 9.88x (vs. prior 6.75x, +46.4% expansion; vs. industry 13.07x, still 24.4% discount), PEG 0.32 (vs. prior 0.20, +57% expansion; vs. industry 0.79, still 60% discount). The valuation remains attractive but has compressed substantially. GROWTH: Next-year EPS growth 29.95% (133% above industry 12.86%), 5-year EPS CAGR 31.22% (43% above industry 21.79%), revenue growth 26.6% (vs. prior 53.5% — 50.3% deceleration; vs. industry 32.96%, now below peers). The revenue growth deceleration from 53.5% to 26.6% is the most concerning new development, potentially signaling that the commodity tailwind is moderating at the revenue line even as EPS projections remain elevated.

News Sentiment

Centerra Gold is hitting on nearly all cylinders right now, and investors are taking notice. The Canadian gold producer is riding a golden wave — literally — with gold futures surging to $4,124.10 per ounce, up over 1% on the day, providing a powerful revenue tailwind for the company's core mining operations. But the real story goes beyond the commodity price. In a signal of management's confidence in the company's financial strength, Centerra announced the TSX acceptance of its renewed Normal Course Issuer Bid — Wall Street speak for 'we're buying back our own stock because we think it's cheap.' That's exactly the kind of corporate self-belief that gets investors excited. Meanwhile, the Thompson Creek molybdenum project is generating serious buzz, with recent analysis suggesting the project 'Could Deliver More Upside After A 71% Rally' — a remarkable headline for what was once a dormant asset. Add in Centerra's strategic investment in Mundoro (a vote of confidence in exploration opportunities), solid Q3 earnings call performance confirming annual guidance adherence, and a planned production commencement at key projects slated for mid-2027, and you have a company actively executing on multiple fronts simultaneously. The Goldfield project development announcements round out a capital allocation story that shows management isn't sitting on its $398 million cash pile — it's deploying it strategically to build tomorrow's production profile. For everyday investors, the bottom line is simple: Centerra is a gold company with money in the bank, projects coming online, and stock buybacks underway, all while gold itself hits historic highs.

Risk Assessment

PRIMARY RISK: FCF deterioration from $92.3M to $10.8M (88% decline) is the most acute near-term risk — if this represents structural earnings quality degradation rather than timing, the EPS growth projections of 29-31% may be overstated and the P/E of 9.88x is less cheap than it appears. SECONDARY RISK: Revenue growth deceleration from 53.5% to 26.6% now below industry average (32.96%), suggesting commodity price tailwinds may not be fully translating to top-line acceleration at CGAU's specific assets. TERTIARY RISK: P/E expansion from 6.75x to 9.88x in 14 days (without a corresponding news catalyst of similar magnitude) suggests some speculative momentum may have entered the name — a retracement toward 8x P/E (approximately $20.00-$20.50) is plausible if gold prices moderate from $4,124/oz. MITIGATION: Stop at $19.00 (9.1% below midpoint entry $20.90) limits downside; $398M cash provides fundamental floor; gold at all-time highs supports royalty/streaming cash flows; Thompson Creek production commencement mid-2027 is a hard catalyst. GOLD PRICE RISK: At $4,124/oz, gold is at extended levels — a 15-20% gold correction would compress CGAU's EPS forecasts and potentially accelerate the P/E multiple compression already underway.

Related Halal Stocks

Related Stocks

Frequently Asked Questions

Is CGAU a halal stock?

No, Centerra Gold Inc. (CGAU) is currently not classified as halal by AAOIFI criteria.

What is Plutrex's AI rating for CGAU?

Centerra Gold Inc. (CGAU) has a Plutrex AI rating of 76.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.

Is CGAU a good investment?

According to Plutrex AI, CGAU has a Buy rating (76.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.

How can I invest in CGAU?

US stocks like CGAU can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.

What are the main risks of investing in CGAU?

Plutrex AI identifies the main risks for CGAU by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.

Chat with ElBarake AI about CGAU

Ask anything about this stock and get an instant AI-powered answer — free, no signup required.

Open CGAU in ElBarake